Researchers at Ohio State University Target B-Cell Lymphoma (Real-world Sequential Use of Cd19-directed Therapies For Relapsed Or Refractory Diffuse Large B-cell Lymphoma: Tafasitamab Preceding Chimeric Antigen Receptor T-cell Therapy)

Source :: Hematology Week. November 4, 2024, 594
Publication Year :: 2024
Abstract: 2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on B-cell lymphoma. According to news originating from Columbus, United States, [...]

Subjects :: Care and treatment
Reports
Non-Hodgkin lymphomas -- Care and treatment
Antigens -- Reports
Biochemistry -- Reports
Stem cells -- Reports
Drug approval -- Reports
Stem cell transplantation -- Reports
T cells -- Reports
Stem cells -- Reports -- Transplantation
Non-Hodgkin's lymphomas -- Care and treatment

Tools